Abstract

Compounded Medications and Probiotics for Irritable Bowel Syndrome

Author(s): Narváez Katherine Rivera, Thompson Tara

Issue: Sep/Oct 2022 - Volume 26, Number 5

Page(s): 378-384

Download in electronic PDF format for $75
  • Compounded Medications and Probiotics for Irritable Bowel Syndrome Page 1
  • Compounded Medications and Probiotics for Irritable Bowel Syndrome Page 2
  • Compounded Medications and Probiotics for Irritable Bowel Syndrome Page 3
  • Compounded Medications and Probiotics for Irritable Bowel Syndrome Page 4
  • Compounded Medications and Probiotics for Irritable Bowel Syndrome Page 5
  • Compounded Medications and Probiotics for Irritable Bowel Syndrome Page 6
  • Compounded Medications and Probiotics for Irritable Bowel Syndrome Page 7

Abstract

Studies have found that the microflora composition of individuals with irritable bowel syndrome and ulcerative colitis differ from those of healthy individuals. Some findings suggest a decrease in beneficial bacteria populations and an increase in pathogenic bacteria populations or a higher abundance of bacteria overall (known as small intestinal bacterial overgrowth in these populations). Pharmaceutical compounders are able to formulate medications that are not available commercially that may provide a more targeted therapy for the treatment of irritable bowel syndrome or ulcerative colitis, or they can provide doses that may otherwise be difficult to achieve with commercially available products. This article discusses these two maladies and the important role of pharmaceutical compounding in their treatment options.

Related Keywords

  • irritable bowel syndrome
  • IBS
  • ulcerative colitis
  • inflammation
  • inflammatory bowel disease
  • probiotics
  • prebiotics
  • gut microflora
  • gastrointestinal microflora
  • small intestinal bacterial overgrowth
  • naltrexone
  • amitriptyline
  • sodium butyrate
  • nifedipine
  • diltiazem
  • short-chain fatty acids
  • erythromycin
  • mesalamine
  • probiotic vehicle
  • formulation
  • tacrolimus

Related Categories

  • FORMULATIONS
  • GASTROENTEROLOGY
  • ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2022
Pg. 378-384
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Author(s): Narváez Katherine Rivera, Thompson Tara
May/Jun 2006
Pg. 195-200
Probiotic Therapy, Part 2: Clinical Perspectives
Author(s): Vail Jane
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Mar/Apr 2010
Pg. 171-173
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Sep/Oct 2000
Pg. 349
Probiotics and Their Effect on Leaky Gut Syndrome and Associated Diseases
Author(s): Hinze John, Mahan Tracy
Mar/Apr 2006
Pg. 107-111
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives
Author(s): Vail Jane
Jan/Feb 2003
Pg. 27-29
Equine Cushing’s Syndrome
Author(s): Vail Jane
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
May/Jun 2019
Pg. 234
Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2002
Pg. 185
Liver Pills for All Obstructions of the Liver, Gall Ducts, and Bowel
Author(s): Worthen Dennis B
May/Jun 2019
Pg. 192-199
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Author(s): Riepl Mike
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Mar/Apr 2005
Pg. 93
Book Review: Bacteria for Breakfast: Probiotics for Good Health
Author(s): Reed-Kane Dana
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Sep/Oct 2013
Pg. 380-383
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
Author(s): McElhiney Linda F
Jan/Feb 2005
Pg. 62
Amitriptyline Hydrochloride 10-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2007
Pg. 187-192
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Author(s): Vail Jane
Mar/Apr 2016
Pg. 155-158
Utilization of Compounded Medications in an Oral Medicine Practice
Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
May/Jun 2016
Pg. 197-201
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Author(s): Sturn Kayla M, Collin Michael